Cargando…
The m(6)A regulator KIAA1429 stabilizes RAB27B mRNA and promotes the progression of chronic myeloid leukemia and resistance to targeted therapy
Chronic myeloid leukemia (CML) is a common adult leukemia. Both the acute phase of the disease and the adverse effects of anti-cancer treatments can lead to a poor prognosis. The N(6)-methyladenine (m(6)A) modification plays an important regulatory role in various physiological and pathological proc...
Autores principales: | Yao, Fangyi, Zhong, Fangmin, Jiang, Junyao, Cheng, Ying, Xu, Shuai, Liu, Jing, Lin, Jin, Zhang, Jing, Li, Shuqi, Li, Meiyong, Xu, Yanmei, Huang, Bo, Wang, Xiaozhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10491918/ https://www.ncbi.nlm.nih.gov/pubmed/37692484 http://dx.doi.org/10.1016/j.gendis.2023.03.016 |
Ejemplares similares
-
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia
por: Zhong, Fangmin, et al.
Publicado: (2022) -
KIAA1429 facilitates progression of hepatocellular carcinoma by modulating m6A levels in HPN
por: Meng, Yu, et al.
Publicado: (2023) -
The biological function of m6A methyltransferase KIAA1429 and its role in human disease
por: Zhang, Xiaoyu, et al.
Publicado: (2022) -
KIAA1429 regulates the migration and invasion of hepatocellular carcinoma by altering m6A modification of ID2 mRNA
por: Cheng, Xiaoyu, et al.
Publicado: (2019) -
m6A ‘writer’ KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis
por: Rong, Jian, et al.
Publicado: (2022)